Loading…
Sunshine Biopharma, Inc. is projected to rise to $2.85 by 2027, a +33% move from its current price of $2.14. SBFM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.03 | $2.14 | $2.26 | +0.17% |
| Jul 13 | $1.99 | $2.15 | $2.31 | +0.35% |
| Jul 14 | $1.97 | $2.15 | $2.35 | +0.52% |
| Jul 15 | $1.94 | $2.15 | $2.39 | +0.69% |
| Jul 16 | $1.92 | $2.16 | $2.43 | +0.87% |
| Jul 17 | $1.90 | $2.16 | $2.46 | +1.04% |
| Jul 18 | $1.89 | $2.17 | $2.49 | +1.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.89 | $2.17 | $2.49 | +1.22% |
| Week 2 | $1.80 | $2.19 | $2.67 | +2.45% |
| Week 3 | $1.75 | $2.22 | $2.82 | +3.69% |
| Week 4 | $1.70 | $2.25 | $2.96 | +4.95% |
| Week 5 | $1.67 | $2.27 | $3.10 | +6.23% |
| Week 6 | $1.64 | $2.30 | $3.23 | +7.52% |
| Week 7 | $1.62 | $2.33 | $3.36 | +8.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products.
In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. The company is based in Fort Lauderdale, Florida.
Sunshine Biopharma, Inc. trades in the Healthcare category with the symbol SBFM. The current price is $2.12, and the market cap is $4.5M. The stock ranks 5380 by market capitalization.
The forecast suggests a gradual upside over time, starting with 2026 where the min, avg, and max are $2.12, $2.12, and $3.52 respectively and sentiment is NEUTRAL.
From 2027 onward, the averages rise, with 2027 at $2.97, 2028 at $3.80, and 2029 at $3.55, highlighting bullish sentiment and rising upside potential. The long-range view extends to 2050, with notable highs in 2040 and 2050 as averages reach $5.08 and $8.69 respectively, and maximums climbing toward $11.16 and $19.99.
A major floor 86.7% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 48.1% above — a clean break opens room to run.
A major ceiling 88.4% above — clearing it would confirm fresh momentum.
Key SBFM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBFM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.12 | Buy | $2.12 | Buy |
| MA 10 | $2.13 | Buy | $2.12 | Buy |
| MA 20 | $2.14 | Sell | $2.07 | Buy |
| MA 50 | $1.60 | Buy | $1.77 | Buy |
| MA 100 | $1.34 | Buy | $1.55 | Buy |
| MA 200 | $1.41 | Buy | $3.75 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.14 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -60.28 | Neutral |
| Williams %R (14) | -64.29 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 2.45 | Buy |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 35.71 | Neutral |
| TRIX (15) | 1.32 | Buy |
| Awesome (5,34) | 0.15 | Buy |
| Ultimate (7,14,28) | 47.16 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 2.11 | Buy |
| ADX (14) | 19.60 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 30. SMA50 is $6.74 and SMA200 is $12.10, placing the price below short- and long-term moving averages. Support is at $2.12 and resistance at $10.80. The thirty-day price range runs from a low of $1.25 to a high of $3.59, and annualized volatility stands at 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.04 | $2.14 | $3.56 | 0% | Neutral | |
| $2.08 | $2.85 | $4.23 | +33% | Bullish | |
| $2.51 | $3.65 | $5.77 | +71% | Bullish | |
| $2.35 | $3.59 | $5.95 | +68% | Bullish | |
| $1.81 | $2.90 | $5.01 | +36% | Bullish | |
| $1.79 | $2.99 | $5.34 | +40% | Bullish | |
| $1.66 | $2.90 | $5.32 | +35% | Bullish | |
| $1.78 | $3.22 | $6.08 | +51% | Bullish | |
| $2.21 | $4.16 | $8.04 | +94% | Bullish | |
| $2.21 | $4.32 | $8.54 | +102% | Bullish | |
| $2.08 | $4.62 | $10.03 | +116% | Bullish | |
| $4.01 | $8.91 | $20.50 | +316% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.04 | $2.14 | $2.74 | +0.00% |
| August 2026 | $2.06 | $2.50 | $3.15 | +16.79% |
| September 2026 | $2.04 | $2.50 | $3.22 | +0.22% |
| October 2026 | $1.93 | $2.40 | $3.14 | -4.08% |
| November 2026 | $2.02 | $2.53 | $3.36 | +5.31% |
| December 2026 | $2.09 | $2.65 | $3.56 | +4.63% |
Click any year to see its month-by-month SBFM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sunshine Biopharma, Inc.'s 2026 outlook centres on $2.14, within a $2.04 to $3.56 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, SBFM could reach as high as $4.23, with a base case around $2.85 and support toward $2.08 — roughly +33% from $2.14. Momentum favours further upside here.
Expect SBFM to range from $2.51 to $5.77 through 2028. The $3.65 average target implies a +71% move from current prices. That is up +28% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The SBFM price prediction for 2029 points to an average of $3.59 (low $2.35, high $5.95) — a potential gain of +68% on today's $2.14. Momentum favours further upside here.
In 2030, SBFM is projected to trade between $1.81 and $5.01, averaging $2.90 — a potential gain of +36% from today's $2.14. That is -19% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Sunshine Biopharma, Inc.'s 2031 outlook centres on $2.99, within a $1.79 to $5.34 range. That is up +3% on the projected 2030 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2032, SBFM could reach as high as $5.32, with a base case around $2.90 and support toward $1.66 — roughly +35% from $2.14. Buyers look set to stay in control over this stretch.
Expect SBFM to range from $1.78 to $6.08 through 2033. The $3.22 average target implies a +51% move from current prices. That is up +11% on the projected 2032 average. Momentum favours further upside here.
The SBFM price prediction for 2034 points to an average of $4.16 (low $2.21, high $8.04) — a potential gain of +94% on today's $2.14. Buyers look set to stay in control over this stretch.
In 2035, SBFM is projected to trade between $2.21 and $8.54, averaging $4.32 — a potential gain of +102% from today's $2.14. That is up +4% on the projected 2034 average. Momentum favours further upside here.
Sunshine Biopharma, Inc.'s 2040 outlook centres on $4.62, within a $2.08 to $10.03 range. That is up +7% on the projected 2035 average. That marks a +116% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, SBFM could reach as high as $20.50, with a base case around $8.91 and support toward $4.01 — roughly +316% from $2.14. Momentum favours further upside here.
Investing $1,000 in SBFM today (≈ 467.28972 SBFM) could be worth
$4,163.98
+$3,163.98 (+316%) by 2050 · US Dollar
Based on the average projected SBFM price of $8.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBFMwould be worth at today's price.
$1,000 invested in SBFM on Jul 10, 2025 (≈ 626.959236 SBFM) would be worth
$1,341.69
+$341.69 (+34.2%) today · 1.34× · US Dollar
Based on a SBFM entry price of $1.6 vs. today's $2.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.11 | $1,014.22 | +1.4% |
| 1 month ago | $2.14 | $1,000 | -0.0% |
| 3 months ago | $0.998 | $2,144.29 | +114.4% |
| 6 months ago | $1.27 | $1,685.04 | +68.5% |
| 1 year ago | $1.6 | $1,341.69 | +34.2% |
| All time (4.4y) ago | $4,780 | $0.45 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBFM forecast.
Our base-case forecast reaches $4.30 around 2035.
Implied market cap at $4.30: $9.13M
The multi-year forecast shows bullish sentiment across the long horizon, with the average price rising from $2.12 in 2026 to $8.69 in 2050. Notable milestones include 2027 average $2.97, 2028 $3.80, 2029 $3.55, and 2030 $2.84, with corresponding growth in max values.
Key longer-dated milestones show stronger upside: 2034 average $4.48 with max $8.76, 2035 average $4.33 with max $8.67, and 2040 average $5.08 with max $11.16. By 2050 the average price is $8.69 with a max of $19.99. The forecast also reports upside in years such as 2031 ($3.20 avg, max $5.77), 2033 ($3.20 avg, max $6.11).
These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030 avg $2.84 with min $1.75 and max $4.94; ROI 34; sentiment BULLISH.
The forecast shows bullish sentiment in several years (e.g., 2027 avg $2.97, 2028 avg $3.80, 2029 avg $3.55) with notable ROIs (39.9, 79.4, 67.7 respectively). However, some years are flat or modest (2026 min/max $2.12/$3.52; ROI 0), and these are estimates, not guarantees.
Yes. The forecast max for 2040 is $11.16.
The 30-day range is $1.25 to $3.59.
Current price is $2.12 and market cap is $4.5M.
Sunshine Biopharma, Inc. Community Discussion
0Share your Sunshine Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.